Anne Husebekk Selected Research

Anne Husebekk Research Topics

Disease

17	Neonatal Alloimmune Thrombocytopenia 07/2020 - 08/2005
7	Thrombocytopenia (Thrombopenia) 01/2017 - 06/2008
7	Neoplasms (Cancer) 12/2016 - 01/2002
3	Inflammation (Inflammations) 01/2021 - 11/2007
3	Birth Weight (Birth Weights) 01/2021 - 01/2012
3	Hemorrhage 07/2020 - 08/2016
3	Lymphoma (Lymphomas) 12/2016 - 01/2002
3	Infections 01/2016 - 01/2002
2	Disease Progression 12/2016 - 05/2015
2	Hepatitis B 07/2012 - 09/2010
2	Ulcerative Colitis 01/2009 - 11/2007
2	Adenoma (Adenomas) 12/2007 - 07/2007
2	Carcinoma (Carcinomatosis) 12/2007 - 07/2007
1	Transfusion Reaction 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 12/2016
1	Leukemia 12/2016
1	Multiple Myeloma 05/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2012
1	Hepatitis 07/2012
1	Virus Diseases (Viral Diseases) 09/2010
1	Purpura 08/2007
1	Colorectal Neoplasms (Colorectal Cancer) 07/2007
1	Carcinogenesis 07/2007
1	Duodenal Ulcer (Curling's Ulcer) 06/2007
1	Residual Neoplasm 04/2004
1	Breast Neoplasms (Breast Cancer) 04/2004
1	Human Influenza (Influenza) 01/2002
1	Pneumococcal Infections 01/2002

Drug/Important Bio-Agent (IBA)

11	AntibodiesIBA 04/2017 - 06/2008
6	Human Platelet AntigensIBA 01/2021 - 01/2016
6	IsoantibodiesIBA 11/2018 - 01/2012
5	human ITGB3 protein (HPA-1a)IBA 01/2021 - 01/2012
4	AntigensIBA 08/2018 - 08/2005
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 01/2017
2	erucylphosphocholineIBA 12/2016 - 05/2015
2	IntegrinsIBA 11/2015 - 06/2015
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2012 - 09/2010
2	Messenger RNA (mRNA)IBA 01/2009 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009 - 11/2007
2	CytokinesIBA 12/2007 - 07/2007
1	Formaldehyde (Formol)FDA Link 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	ParaffinIBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	EpitopesIBA 01/2017
1	SolutionsIBA 08/2016
1	LeptinIBA 02/2016
1	C-Reactive ProteinIBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Isoantigens (Alloantigen)IBA 01/2016
1	Interleukin-15 (Interleukin 15)IBA 10/2012
1	Interleukin-2 (IL2)IBA 10/2012
1	SuspensionsIBA 10/2012
1	Interleukin-7 (Interleukin 7)IBA 10/2012
1	Proteoglycans (Proteoglycan)IBA 10/2012
1	Surface Antigens (Surface Antigen)IBA 07/2012
1	EnzymesIBA 07/2012
1	Hepatitis B Core AntigensIBA 07/2012
1	Hepatitis C AntigensIBA 07/2012
1	ABO Blood-Group SystemIBA 01/2012
1	HLA-DRB3 Chains (HLA DRB3)IBA 04/2009
1	Infliximab (Remicade)FDA Link 01/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2007
1	Interleukin-6 (Interleukin 6)IBA 12/2007
1	Interleukin-12 (IL 12)IBA 12/2007
1	InterleukinsIBA 12/2007
1	Interleukin-18 (Interleukin 18)IBA 12/2007
1	InterferonsIBA 12/2007
1	AntralIBA 06/2007
1	RNA (Ribonucleic Acid)IBA 04/2004
1	Epidermal Growth Factor (EGF)IBA 04/2004
1	ErbB Receptors (EGF Receptor)IBA 04/2004
1	Complementary DNA (cDNA)IBA 04/2004
1	Epithelial Cell Adhesion MoleculeIBA 04/2004
1	Keratin-19 (Keratin 19)IBA 04/2004

Therapy/Procedure

2	Stem Cell Transplantation 01/2017 - 05/2015
2	Transplantation 12/2016 - 05/2015
2	Therapeutics 05/2015 - 01/2009
1	Hematopoietic Stem Cell Transplantation 12/2016
1	Blood Transfusion (Blood Transfusions) 07/2012
1	Cesarean Section (Caesarean Section) 08/2007
1	Drug Therapy (Chemotherapy) 01/2002